Renal Medical Devices Service Market Report 2026

The renal medical devices service market size has grown steadily in recent years. It will grow from $10.1 billion in 2025 to $10.55 billion in 2026 at a compound annual growth rate (CAGR) of 4.4%. The growth in the historic period can be attributed to increasing prevalence of kidney diseases, expansion of dialysis centers globally, rising installation of advanced dialysis equipment, need for regulatory compliance in device maintenance, availability of specialized renal devices.

The renal medical devices service market size is expected to see steady growth in the next few years. It will grow to $12.4 billion in 2030 at a compound annual growth rate (CAGR) of 4.1%. The growth in the forecast period can be attributed to increasing demand for home dialysis services, rising adoption of connected renal devices, expansion of service outsourcing models, growing focus on cost-efficient healthcare operations, increasing use of analytics for device performance optimization. Major trends in the forecast period include increasing adoption of predictive maintenance services, growing use of remote device monitoring solutions, expansion of preventive service contracts, enhanced focus on equipment uptime and safety, rising integration of data-driven service models.

The rising prevalence of chronic kidney disease (CKD) is expected to drive the growth of the renal medical devices service market going forward. Chronic kidney disease is a condition in which the kidneys gradually lose their ability to filter waste products from the blood, resulting in the accumulation of toxins and other health complications. The prevalence of CKD is increasing due to diabetes, as elevated blood sugar levels damage kidney blood vessels, impairing their filtration capacity. Renal medical device services support CKD management by ensuring optimal performance of dialysis and related equipment. Timely maintenance and technical support reduce downtime, enhancing treatment reliability and patient care. For instance, in June 2023, according to Kidney Research UK, a UK-based charity focused on kidney disease research and advocacy, an estimated 7.19 million people in the UK were affected by CKD in 2023, representing over 10% of the population, with projections indicating an increase to 7.61 million by 2033. Therefore, the rising prevalence of CKD is driving growth in the renal medical devices service market.

The increasing healthcare expenditure is expected to further propel the growth of the renal medical devices service market. Healthcare expenditure refers to the total spending on medical services, treatments, facilities, research, and public health initiatives aimed at maintaining or improving health outcomes. The rise in healthcare expenditure is driven by the growing burden of chronic diseases, which require ongoing treatment and management, resulting in higher long-term medical costs. Increased healthcare expenditure supports renal medical device services by enabling investments in advanced dialysis technologies and maintenance, ensuring better access to quality care and improving treatment efficiency and patient outcomes in CKD management. For instance, in December 2024, according to the Centers for Medicare and Medicaid Services (CMS), a US-based federal agency, national health expenditures (NHE) increased by 7.5% to $4.9 trillion in 2023, accounting for 17.6% of GDP. Between 2023 and 2032, NHE is projected to grow at an average annual rate of 5.6%, raising the share of health spending in GDP from 17.3% in 2022 to 19.7% in 2032. Therefore, the increasing healthcare expenditure is driving the growth of the renal medical devices service market.

Major companies in the renal medical devices service market are focusing on developing technologically advanced solutions, such as hypothermic perfusion technology, to enhance organ viability and patient outcomes. Hypothermic perfusion technology is an organ preservation method in which a cold, oxygenated solution is continuously pumped through donor organs at low temperatures (typically 0-12°C) to maintain viability prior to transplantation. For instance, in January 2025, Paragonix Technologies Inc., a US-based medical device company, received FDA clearance for the KidneyVault portable renal perfusion system for hypothermic oxygenated perfusion of kidneys. This portable system preserves kidney viability during transport using hypothermic machine perfusion and SherpaCool phase-change cooling to maintain temperatures between 4-8°C without ice. Its integrated digital platform provides real-time monitoring of temperature, pressure, flow, and resistance, enabling remote management of organ preservation.

Major companies operating in the renal medical devices service market are Abbott Laboratories, Medtronic plc, Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Medical Co Ltd., Toray Medical Co Ltd., Boston Scientific Corporation, DaVita Inc., Terumo Corporation, Nipro Corporation, Teleflex Incorporated, ConvaTec Group Plc, Nikkiso Co Ltd., Japan Medical Supply Co Ltd., NxStage Medical Inc., B. Braun Melsungen AG, Outset Medical Inc., Rockwell Medical Inc., Quanta Dialysis Technologies Ltd., AWAK Technologies Pte Ltd., Dialife SA.

North America was the largest region in the renal medical devices service market in 2025. The regions covered in the renal medical devices service market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the renal medical devices service market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the renal medical devices service market by increasing costs of imported dialysis machines, sensors, replacement parts, electronic modules, and maintenance tools required for servicing activities. Hospitals and dialysis centers in North America and Europe are most affected due to reliance on imported renal equipment, while Asia-Pacific faces increased servicing costs for advanced devices. These tariffs are raising service contract prices and maintenance expenses. However, they are also encouraging local servicing capabilities, regional spare parts manufacturing, and investment in domestic technical service infrastructure.

The renal medical devices service market research report is one of a series of new reports that provides renal medical devices service market statistics, including renal medical devices service industry global market size, regional shares, competitors with a renal medical devices service market share, detailed renal medical devices service market segments, market trends and opportunities, and any further data you may need to thrive in the renal medical devices service industry. This renal medical devices service market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Renal medical device service refers to the specialized support and maintenance provided for medical devices used in kidney care, such as dialysis machines and related equipment. The primary purpose of these services is to ensure that devices operate safely, efficiently, and reliably to support effective patient treatment.

The primary types of renal medical device services include dialysis devices, catheters, kidney monitoring devices, and kidney transplant devices. Dialysis devices are specialized medical instruments designed to filter and purify the blood in patients with impaired kidney function. These devices are used in both invasive and non-invasive procedures for conditions such as kidney failure, chronic kidney disease, end-stage kidney disease, renal stone disease, and hypertension. They are widely utilized by hospitals, dialysis centers, and home healthcare providers.

The renal medical device service market includes revenues earned by entities through installation, maintenance, repair, calibration, technical support, and training services related to medical devices used in kidney care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.